TABLE 7.
Management of HBV in the exposed individual.
Hepatitis B status of source individual | HBV vaccination status of exposed individual |
|||
---|---|---|---|---|
Not vaccinated | Fully vaccinated, documented responder (HBsAb titre ≥ 10 mIU/mL) | Vaccinated, documented non-responder (HBsAb titre < 10 mIU/mL) | Vaccinated, HBsAb status unknown | |
HbsAg positive, or HbsAg unknown |
|
|
|
Test exposed individual’s HBsAb‡: |
|
|
|
||
|
||||
HbsAg negative | Initiate hepatitis B vaccine series |
|
|
Test exposed individual’s HBsAb: |
|
||||
|
Source: Adapted from National Guidelines for the Management of Viral Hepatitis. National Department of Health; c2019 [cited 2023 Jul 13]. Available from: https://knowledgehub.health.gov.za
HbsAg, hepatitis B surface antigen; HBIG, hepatitis B immunoglobulin; IM, intra-muscular; HBsAb, Hepatitis B surface antibodies.
HBIG and first dose of vaccine should be administered simultaneously, at different sites.
If testing for HBsAb will be delayed for > 24 h, treat as non-responder.